INVO Fertility (IVF) Long-Term Deferred Tax (2019 - 2020)
INVO Fertility (IVF) reported Long-Term Deferred Tax of $468.0 for Q4 2020, up 8.08% year-over-year from $433.0 in Q1 2020, and up 8.08% sequentially from $433.0 in Q4 2019.
INVO Fertility (IVF) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends
INVO Fertility has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $468.0 for Q4 2020.
- Quarterly Long-Term Deferred Tax rose 8.08% year-over-year to $468.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $468.0 (up 8.08% YoY) and the FY2020 annual result came in at $468.0, up 8.08% from the prior year.
- Long-Term Deferred Tax advanced to $468.0 in Q4 2020, from $433.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $468.0 in Q4 2020 and bottomed at $433.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 468.00 |
| Dec 31, 2019 | 433.00 |